John holds a master’s degree in Cell and Tissue Engineering and a PhD in Bioengineering and Regenerative Medicine. With 10 years of experience in cell therapies, John contributed to clinical trials for cartilage regeneration at the RJAH Orthopaedic Hospital before joining the GMP CAR T cell manufacturing team in 2020. John’s current role involves technology transfers, initiating new trials, process optimisation and the adoption of new platforms for CAR T cell manufacturing.